Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eprosartan in Healthy Humans
NCT00409903Phase 4
Key facts
- Status
- Completed
- Start
- Nov 2006
- Countries
- 1
- Sponsor
- Regionshospitalet Holstebro
- Modality
- Small Molecules
- Drugs
- eprosartan
- Conditions
- hypertension (HTN)
01
Overview
Phase 4 trial of eprosartan in hypertension (HTN), sponsored by Regionshospitalet Holstebro. Primary endpoints: Heart rate, Fractional sodium excretion and 1 more. Started Nov 2006; status: completed.
02
Design
1 armEprosartan
Healthy volunteers receiving Eprosartan
03
Who it enrols
Healthy volunteers aged 18-65 with BMI <= 30, normal blood pressure, and no history of significant diseases or substance abuse.
04
Endpoints
Primary
Heart rate
Fractional sodium excretion
Plasma levels of noradrenaline
Beyond the preview
Go deeper on NCT00409903.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00409903.